Nanobiotix NBTX Stock
Nanobiotix Price Chart
Nanobiotix NBTX Financial and Trading Overview
| Nanobiotix stock price | 34.5 USD |
| Previous Close | 35.88 USD |
| Open | 34.89 USD |
| Bid | 33.7 USD x 300 |
| Ask | 35.4 USD x 100 |
| Day's Range | 33.01 - 35.6 USD |
| 52 Week Range | 12.63 - 57.14 USD |
| Volume | 149.34K USD |
| Avg. Volume | 139.19K USD |
| Market Cap | 1.68B USD |
| Beta (5Y Monthly) | 0.566 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.58 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 54.14 USD |
NBTX Valuation Measures
| Enterprise Value | 1.64B USD |
| Trailing P/E | N/A |
| Forward P/E | -115.272125 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 51.523792 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 50.372 |
| Enterprise Value/EBITDA | -156.525 |
Trading Information
Nanobiotix Stock Price History
| Beta (5Y Monthly) | 0.566 |
| 52-Week Change | 156.99% |
| S&P500 52-Week Change | 14.29% |
| 52 Week High | 57.14 USD |
| 52 Week Low | 12.63 USD |
| 50-Day Moving Average | 39.24 USD |
| 200-Day Moving Average | 32.88 USD |
NBTX Share Statistics
| Avg. Volume (3 month) | 139.19K USD |
| Avg. Daily Volume (10-Days) | 133.29K USD |
| Shares Outstanding | 50.81M |
| Float | 33.88M |
| Short Ratio | 0.88 |
| % Held by Insiders | 0% |
| % Held by Institutions | 11.94% |
| Shares Short | 149.22K |
| Short % of Float | 0.40% |
| Short % of Shares Outstanding | 0.28% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -73.51% |
| Operating Margin (ttm) | -196.42% |
| Gross Margin | 100.00% |
| EBITDA Margin | -32.18% |
Management Effectiveness
| Return on Assets (ttm) | -10.062% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 32.59M USD |
| Revenue Per Share (ttm) | 0.68 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 32.59M USD |
| EBITDA | -10489000 USD |
| Net Income Avi to Common (ttm) | -23961000 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 52.75M USD |
| Total Cash Per Share (mrq) | 1.09 USD |
| Total Debt (mrq) | 95.32M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.091 |
| Book Value Per Share (mrq) | -2.0239458 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33422000 USD |
| Levered Free Cash Flow (ttm) | -7894125 USD |
Profile of Nanobiotix
| Country | United States |
| State | N/A |
| City | Paris |
| Address | 60 rue de Wattignies |
| ZIP | 75012 |
| Phone | 33 1 40 26 04 70 |
| Website | https://www.nanobiotix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 100 |
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Q&A For Nanobiotix Stock
What is a current NBTX stock price?
Nanobiotix NBTX stock price today per share is 34.5 USD.
How to purchase Nanobiotix stock?
You can buy NBTX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nanobiotix?
The stock symbol or ticker of Nanobiotix is NBTX.
Which industry does the Nanobiotix company belong to?
The Nanobiotix industry is Biotechnology.
How many shares does Nanobiotix have in circulation?
The max supply of Nanobiotix shares is 50.81M.
What is Nanobiotix Price to Earnings Ratio (PE Ratio)?
Nanobiotix PE Ratio is now.
What was Nanobiotix earnings per share over the trailing 12 months (TTM)?
Nanobiotix EPS is -0.58 USD over the trailing 12 months.
Which sector does the Nanobiotix company belong to?
The Nanobiotix sector is Healthcare.
Nanobiotix NBTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27122.09 USD — |
+2.26
|
7.86B USD — | 26707.42 USD — | 27183.93 USD — | — - | 7.86B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
13333.67 USD — |
+2.28
|
— — | 13126.46 USD — | 13364.18 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1323.55 USD — |
+0.88
|
— — | 1309.56 USD — | 1327.32 USD — | — - | — — |
- {{ link.label }} {{link}}
